Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized phase II study of TJ-3020 for fatigue in pancreatic cancer patients on nab-paclitaxel plus gemcitabine
jRCTs041190040Phase 2Completed
- Start
- Dec 2017
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of red ginseng powder in pancreatic cancer (PC) (2 arms). Primary endpoint: Fatigue and malaise assessment. Started Dec 2017; status: completed.
02
Drugs
red ginseng powder
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on jRCTs041190040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041190040.